docetaxel
Generic: docetaxel anhydrous
Labeler: mylan institutional llcDrug Facts
Product Profile
Brand Name
docetaxel
Generic Name
docetaxel anhydrous
Labeler
mylan institutional llc
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
docetaxel anhydrous 10 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
67457-533
Product ID
67457-533_aa6fbb17-6b11-4cc2-9798-edf1e4befd47
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA208859
Listing Expiration
2026-12-31
Marketing Start
2018-09-05
Pharmacologic Class
Established (EPC)
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
67457533
Hyphenated Format
67457-533
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
docetaxel (source: ndc)
Generic Name
docetaxel anhydrous (source: ndc)
Application Number
ANDA208859 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 10 mg/mL
Packaging
- 1 VIAL, MULTI-DOSE in 1 CARTON (67457-533-16) / 16 mL in 1 VIAL, MULTI-DOSE
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "aa6fbb17-6b11-4cc2-9798-edf1e4befd47", "openfda": {"nui": ["N0000175085", "N0000175592"], "upc": ["0367457533162", "0367457532080"], "unii": ["699121PHCA"], "rxcui": ["1093280", "1860619"], "spl_set_id": ["2fb017fd-e55e-43ef-9024-07f2d412b37b"], "pharm_class_pe": ["Microtubule Inhibition [PE]"], "pharm_class_epc": ["Microtubule Inhibitor [EPC]"], "manufacturer_name": ["Mylan Institutional LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, MULTI-DOSE in 1 CARTON (67457-533-16) / 16 mL in 1 VIAL, MULTI-DOSE", "package_ndc": "67457-533-16", "marketing_start_date": "20180905"}], "brand_name": "Docetaxel", "product_id": "67457-533_aa6fbb17-6b11-4cc2-9798-edf1e4befd47", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Microtubule Inhibition [PE]", "Microtubule Inhibitor [EPC]"], "product_ndc": "67457-533", "generic_name": "DOCETAXEL ANHYDROUS", "labeler_name": "Mylan Institutional LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Docetaxel", "active_ingredients": [{"name": "DOCETAXEL ANHYDROUS", "strength": "10 mg/mL"}], "application_number": "ANDA208859", "marketing_category": "ANDA", "marketing_start_date": "20180905", "listing_expiration_date": "20261231"}